any

TCG World Metaverse and Procedural Worlds Craft Vast and Vivid Landscapes with Groundbreaking Technology

New York, November 11, 2023. In a landmark year of collaboration, TCG World Metaverse has joined forces with the talented team at Procedural Worlds to forge a sprawling and immersive environment within the burgeoning metaverse sector. Covering an impressive 900 square kilometers, TCG World has been meticulously sculpted into four distinct regions: North, East, Forest, and Asia. Each quadrant boasts its own unique biome and atmosphere, thanks to the innovative suite of tools provided by Procedural Worlds — Gaia, GeNa, and the revolutionary new software, Storm. Procedural Worlds' artisans have

Koat.ai and Plato AI Announce Strategic Partnership to Revolutionize Data Intelligence and Drive Innovation.

New York, USA November 9, 2023.  Koat.ai, a next-generation social listening and intelligence platform, and Plato AI, a pioneer in open intelligence solutions, announced today a strategic partnership aimed at transforming the landscape of data intelligence and innovation. At the forefront of data intelligence, Koat.ai is a comprehensive and actionable market insights platform powered by AI. The company's proprietary manipulation detection technology enables it to identify both human and manipulated (inorganic) accounts, providing unparalleled clarity of insight and data. With granular sentiment analysis, quantified emotions, and real-time abnormality alerts, Koat.ai

NKGEN Biotech Received FDA Approval for Clinical Trials of SKN01 NK Cell Therapy in Alzheimer’s Disease Treatment.

Summary: Progress in Neurodegenerative Research:  NKGen’s Phase 1/2a Clinical Trial for SNK01 on Track for End-of-Year Initiation SANTA ANA, Calif., Oct. 24, 2023 (Plato / Amplifi) -- Today, NKGen Biotech Inc. (Nasdaq: NKGN), a trailblazer in the field of autologous, allogeneic, and CAR-NK natural killer cell therapeutics, proudly announced the progression of its SNK01 program targeting Alzheimer’s Disease (AD), backed by the green light from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application. NKGen is gearing up to initiate its Phase 1/2a clinical trial

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

HealthCare AI: The Unavoidable Revolution in Modern Medicine

By Eric Greenberg www.linkedin.com/in/ericabg In the evolving landscape of medical technology, there's one force that stands head and shoulders above the rest, promising a seismic shift in the very ethos of healthcare delivery: Artificial Intelligence (AI). As a seasoned technology and banking analyst, it is my considered opinion that Healthcare AI isn't just a trend or a buzzword. It’s the very future of medicine, poised to reshape everything we know about patient care, disease diagnosis, and medical research. To begin with, the economic implications of integrating AI in healthcare are

The Tightrope of Regulation

In a significant move at the recent G20 meeting in India, the International Monetary Fund (IMF) and the Financial Stability Board (FSB) released a joint paper outlining a framework for the global regulation of cryptocurrencies. While the proposals mostly tread familiar territory, what’s new is their conviction in crypto’s unstoppable growth and success. A flurry of optimism greeted the G20’s endorsement of the report because it advocates that countries don’t ban crypto. Hidden in its text, however, are some worrying signs. For example, on the first page, they state, “Widespread

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Do you know baccarat, the flower of online casino games?

Baccarat is one of the most popular card games in casinos, and involves comparing cards between the player and the banker (or dealer) to determine the winner. The rules of Baccarat are simple, but it is a game that can be enjoyed in a variety of ways. Baccarat first appeared in online casino games in the mid-1900s when the Internet became popular. It was limited in the beginning, but in the 2000s, improvements in computer graphics and Internet speeds made it possible to provide a more realistic gaming environment, which

Welcome Renal Warriors

I am a 68 year old man born in Brooklyn, New York and living for decades in Ithaca, NY. I also have 10 years each with homes in @San Ramon, Costa Rica and @Austin, Texas. My present and future dreams are in #Africa and I am setting up a base in @CapeTown, South Africa. #notmytimetodie #supportmymiracle #childofimmigrants #latebloomer. I was told a year ago that I would certainly die if I did not have not follow the standard treatment of care. I rejected both dialysis and a transplant and am

American Picture House Corporate Update

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -

Starbox Group’s StarboxAI – ViPro Module: Transforming Content Creation

Kuala Lumpur, Malaysia, Sept 5th, 2023 – Starbox Group Holdings Ltd. (Nasdaq: STBX), a dynamic player in cash rebates, digital advertising, and payment solutions, with a vision of leading in artificial intelligence (“AI”) solutions throughout Southeast Asia, is making waves with the launch of its groundbreaking StarboxAI - ViPro module. This innovative module introduces a text-to-video feature set to redefine content creation. The Text-to-Video feature within the StarboxAI - ViPro module is not just an addition; it's a revelation. It empowers content creators to seamlessly transmute textual instructions or scripts

The Collision of Titans: AI and Web3

Over the past decade, two titans have emerged from the tech realm, each promising to redefine the very fabric of our global infrastructure - Artificial Intelligence (AI) and Web3. But what happens when these two forces converge? Are we on the brink of a new digital renaissance or a potentially uncharted dystopia? Consider this: AI is, at its core, the embodiment of advanced logic and decision-making, a machine's ability to "think" and process information in ways eerily similar to humans. It's no longer just about algorithms; it's about creating synthetic